Streetbeat News

Regulatory

TNXP

Tonix Pharmaceuticals announced data supporting the memory- and cognition-enhancing effects of TNX-601 ER and TNX-4300. TNX-601 ER is being tested for the treatment of major depressive disorder, with results expected in Q1 2024. TNX-4300 is in preclinical development for mood disorders, Alzheimer's disease, and Parkinson's disease. The findings suggest a role for PPAR-β/δ activation in memory.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:05 am

GSK

PFE

ViiV Healthcare, owned by GSK and Pfizer, has received a positive opinion from the European Medicines Agency's CHMP recommending approval of Cabotegravir long-acting injectable and tablets for HIV prevention.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:03 am

FXI

China's forex regulator has announced that eligible science and technology enterprises may participate in the cross-border financing facilitation business, according to Reuters.

Portfolio Pulse from Charles Gross

July 24, 2023 | 10:58 am

FXI

China's forex regulator plans to ease restrictions on upfront costs for overseas direct investment. This move will also facilitate payment and use of equity transfer funds and funds raised from overseas listing under domestic reinvestment of foreign-invested enterprises.

Portfolio Pulse from Charles Gross

July 24, 2023 | 10:56 am

FXI

China's forex regulator has issued draft measures aimed at facilitating cross-border trade and investment. The move is seen as a step towards liberalizing the country's capital account.

Portfolio Pulse from Charles Gross

July 24, 2023 | 10:50 am

ABNB

AMD

AXP

SLB

The S&P 500 and Dow Jones recorded slight gains on Friday, while the Nasdaq 100 also rose by 0.20%. Schlumberger Limited reported worse-than-expected Q2 revenue results, causing its shares to fall by 2.2%. American Express Company reported better-than-expected Q2 earnings and reaffirmed its FY23 outlook. The Fed is expected to increase interest rates by 25 basis points this week. The CBOE Volatility Index fell by 3.5%.

Portfolio Pulse from Lisa Levin

July 24, 2023 | 10:45 am

IMGN

ImmunoBiochem has entered into a multi-target license and option agreement with ImmunoGen. As part of the agreement, ImmunoGen will pay ImmunoBiochem an upfront fee for an exclusive license to existing antibodies. ImmunoBiochem will be eligible to receive milestone payments and royalties based on the achievement of pre-specified development, regulatory, and commercial milestones.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:35 am

ETHUSD

Ethereum co-founder, Vitalik Buterin, has expressed concerns about WorldCoin's proof-of-personhood system as the cryptocurrency goes live on Binance. Buterin highlighted the importance of proof of personhood in preventing manipulation of decentralized governance by wealthy actors and hostile governments. He pointed out potential risks associated with government-backed identity systems, including privacy breaches, limited accessibility, potential centralization, and security vulnerabilities. He also suggested that a combination of different approaches may be the most effective solution.

Portfolio Pulse from Mehab Qureshi

July 24, 2023 | 10:12 am

EEMA

EWU

EZU

FLAX

SPY

On Friday, July 20, the U.S. Markets ended mixed, with Dow Jones continuing its winning streak for the tenth day. Over 75% of S&P 500 companies that have disclosed quarterly results thus far have exceeded profit estimates. The U.S. Federal Reserve is expected to raise interest rates again on July 26, 2023. Asian and European markets showed mixed results, with Japan's Nikkei 225 and Germany's DAX index trading higher, while Australia's S&P/ASX 200 and France's CAC 40 traded lower. Commodities and US futures were generally trading higher.

Portfolio Pulse from Akanksha Bakshi

July 24, 2023 | 9:55 am

FXI

Chinese President Xi Jinping has stated that China will strive to achieve its annual development goals, according to Reuters. This could potentially impact the iShares China Large-Cap ETF (FXI).

Portfolio Pulse from Charles Gross

July 24, 2023 | 9:44 am